World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   128 records for 34 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02219100
Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus
29/07/2014
RecruitingISRCTN63697536
An efficacy and safety study comparing the fixed combination of two antihypertensive agents, indapamide and amlodipine in a single-pill, to the same drugs given separately, in patients with mild to moderate uncontrolled essential hypertension
28/04/2014
Not recruitingNCT02082340
Innovative Approach in Tuberculosis Care in Armenia
04/03/2014
Not RecruitingEUCTR2010-022134-89-HU
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2010-022134-89-SIEfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.15/11/2013
AuthorisedEUCTR2010-022134-89-ESEfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.01/10/2013
AuthorisedEUCTR2010-022134-89-CZEfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.17/10/2013
AuthorisedEUCTR2010-022134-89-ITEfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.20/09/2013
Not RecruitingEUCTR2010-022134-89-NLEfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.04/10/2013
Not RecruitingEUCTR2010-022134-89-EEEfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.14/10/2013
Not RecruitingEUCTR2010-022134-89-LTEfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.24/10/2013
Not RecruitingEUCTR2010-022134-89-DKEfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.23/01/2014
AuthorisedEUCTR2010-022134-89-ATEfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.03/02/2014
AuthorisedEUCTR2010-022134-89-HREfficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.29/08/2014
11/09/2013
AuthorisedEUCTR2012-005401-41-GB
A trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2012-005401-41-NLA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).25/07/2013
AuthorisedEUCTR2012-005401-41-ATA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).01/07/2013
AuthorisedEUCTR2012-005401-41-SEA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).14/06/2013
AuthorisedEUCTR2012-005401-41-PTA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).24/06/2013
AuthorisedEUCTR2012-005401-41-DKA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).30/07/2013
AuthorisedEUCTR2012-005401-41-ESA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).12/07/2013
AuthorisedEUCTR2012-005401-41-HUA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).11/07/2013
AuthorisedEUCTR2012-005401-41-IEA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).14/06/2013
AuthorisedEUCTR2012-005401-41-FIA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).03/07/2013
AuthorisedEUCTR2012-005401-41-NOA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).27/06/2013
AuthorisedEUCTR2012-005401-41-GRA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).08/07/2013
AuthorisedEUCTR2012-005401-41-PLA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).16/09/2013
RecruitingNCT01908829A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)24/07/2013
AuthorisedEUCTR2012-005401-41-SIA trial comparing combination treatment (solifenacin plus mirabegron) with one treatment alone (solifenacin).12/07/2013
07/06/2013
Not recruitingISRCTN00943368
ObsErvationAl Study to analYse titration of the new Diamicron MR 60 mg formulation in daily clinical practice in a large population with uncontrolled type 2 diabetes
25/02/2013
Not recruitingNCT01766388
Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia
06/12/2012
Not recruitingNCT01630356
Controlled Trial to Reduce Secondhand Smoke Exposure at Homes in Armenia
26/06/2012
Not RecruitingEUCTR2011-005872-41-SE
Comparison of efficacy and safety of Qutenza vs Lyrica
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2011-005872-41-FIComparison of efficacy and safety of Qutenza vs Lyrica03/04/2012
AuthorisedEUCTR2011-005872-41-HUComparison of efficacy and safety of Qutenza vs Lyrica18/05/2012
AuthorisedEUCTR2011-005872-41-ESComparison of efficacy and safety of Qutenza vs Lyrica12/04/2012
AuthorisedEUCTR2011-005872-41-GBComparison of efficacy and safety of Qutenza vs Lyrica18/04/2012
Not RecruitingEUCTR2011-005872-41-DEComparison of efficacy and safety of Qutenza vs Lyrica19/04/2012
Not RecruitingEUCTR2011-005872-41-ATComparison of efficacy and safety of Qutenza vs Lyrica11/04/2012
Not RecruitingEUCTR2011-005872-41-GRComparison of efficacy and safety of Qutenza vs Lyrica30/04/2012
Not RecruitingEUCTR2011-005872-41-ITComparison of efficacy and safety of Qutenza versus Lyrica03/08/2012
Not RecruitingEUCTR2011-005872-41-SKComparison of efficacy and safety of Qutenza vs Lyrica12/04/2012
Not RecruitingEUCTR2011-005872-41-CZComparison of efficacy and safety of Qutenza vs Lyrica15/03/2012
Not RecruitingEUCTR2011-005872-41-PTComparison of efficacy and safety of Qutenza vs Lyrica12/06/2012
Not RecruitingEUCTR2011-005872-41-BGComparison of efficacy and safety of Qutenza vs Lyrica21/08/2012
Not RecruitingEUCTR2011-005872-41-SIComparison of efficacy and safety of Qutenza vs Lyrica17/04/2012
Not RecruitingEUCTR2011-005872-41-BEComparison of efficacy and safety of Qutenza vs Lyrica13/04/2012
Not recruitingNCT01713426A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment22/10/2012
13/03/2012
Not RecruitingEUCTR2011-005713-37-IE
A study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2011-005713-37-ESA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.29/03/2012
Not RecruitingEUCTR2011-005713-37-HUA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.03/05/2012
Not RecruitingEUCTR2011-005713-37-BGA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.31/07/2012
Not RecruitingEUCTR2011-005713-37-NLA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.14/05/2012
Not RecruitingEUCTR2011-005713-37-DEA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.28/03/2012
Not RecruitingEUCTR2011-005713-37-FIA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.05/03/2012
Not RecruitingEUCTR2011-005713-37-GBA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.02/04/2012
Not RecruitingEUCTR2011-005713-37-NOA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.26/04/2012
Not RecruitingEUCTR2011-005713-37-ATA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.10/04/2012
Not RecruitingEUCTR2011-005713-37-GRA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.27/04/2012
Not RecruitingEUCTR2011-005713-37-LVA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.14/05/2012
Not RecruitingEUCTR2011-005713-37-PLA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.05/06/2012
Not RecruitingEUCTR2011-005713-37-ITA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.06/08/2012
Not RecruitingEUCTR2011-005713-37-LTA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.06/06/2012
Not RecruitingEUCTR2011-005713-37-SEA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.15/03/2012
Not RecruitingEUCTR2011-005713-37-CZA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.12/03/2012
Not RecruitingEUCTR2011-005713-37-PTA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.21/05/2012
Not RecruitingEUCTR2011-005713-37-DKA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.09/05/2012
Not RecruitingEUCTR2011-005713-37-SIA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.15/06/2012
Not recruitingNCT01638000A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment09/07/2012
Not RecruitingEUCTR2011-005713-37-BEA study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment.16/04/2012
09/02/2012
    
1 2 3 4
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history